These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11428597)

  • 21. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
    J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients.
    Schnetzler B; Leger P; Völp A; Dorent R; Pavie A; Gandjbakhch I
    Transpl Int; 2002 Jun; 15(6):317-25. PubMed ID: 12072903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
    Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
    J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart transplantation: intraoperative management, postoperative therapy and complications.
    Haverich A; Dammenhayn L; Albes J; Ziemer G; Schmid C; Wahlers T; Schäfers HJ; Wagenbreth I; Borst HG
    Thorac Cardiovasc Surg; 1990 Oct; 38(5):280-4. PubMed ID: 2124733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.
    Erickson KW; Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Zucker MJ; Pifarré R; Lawless CE; Robinson JA; Scanlon PJ
    J Heart Transplant; 1990; 9(5):526-37. PubMed ID: 2231091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential role of T-cell memory distribution as predisposing factor for rejection in heart transplant recipients.
    Lanio N; Sarmiento E; Gallego A; Fernández-Yánez J; Palomo J; Pérez-Rojas J; Carbone J
    Transplant Proc; 2009; 41(6):2480-4. PubMed ID: 19715957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients.
    Battes LC; Caliskan K; Rizopoulos D; Constantinescu AA; Robertus JL; Akkerhuis M; Manintveld OC; Boersma E; Kardys I
    Transplantation; 2015 Mar; 99(3):580-5. PubMed ID: 25136844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda.
    Chinnock R; Emery J; Larsen R; Baum M; Janner D; Razzouk A; Gundry S; Nehlsen-Cannarella S; Bailey L
    J Heart Lung Transplant; 1995; 14(4):726-33. PubMed ID: 7578182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
    Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
    J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up.
    Dobbels F; De Geest S; van Cleemput J; Droogne W; Vanhaecke J
    J Heart Lung Transplant; 2004 Nov; 23(11):1245-51. PubMed ID: 15539122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose tacrolimus/sirolimus and steroid withdrawal in heart recipients is highly efficacious.
    Meiser B; Kaczmarek I; Mueller M; Groetzner J; Weis M; Knez A; Stempfle HU; Klauss V; Schmoeckel M; Reichart B; Ueberfuhr P
    J Heart Lung Transplant; 2007 Jun; 26(6):598-603. PubMed ID: 17543783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis after heart transplantation: twenty years of experience in a single center in Taiwan.
    Chou NK; Wang JL; Chi NH; Wu IH; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Su HY; Chang SC; Chu SH; Wang SS
    Transplant Proc; 2008 Oct; 40(8):2631-3. PubMed ID: 18929823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients.
    Falck P; Asberg A; Guldseth H; Bremer S; Akhlaghi F; Reubsaet JL; Pfeffer P; Hartmann A; Midtvedt K
    Transplantation; 2008 Jan; 85(2):179-84. PubMed ID: 18212621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative pretransplant serostatus for Toxoplasma gondii is associated with impaired survival after heart transplantation.
    Doesch AO; Ammon K; Konstandin M; Celik S; Kristen A; Frankenstein L; Müller S; Sack FU; Katus HA; Dengler TJ
    Transpl Int; 2010 Apr; 23(4):382-9. PubMed ID: 19912587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients.
    Itescu S; Tung TC; Burke EM; Weinberg AD; Mancini D; Michler RE; Suciu-Foca NM; Rose EA
    Lancet; 1998 Jul; 352(9124):263-70. PubMed ID: 9690405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unfavorable outcome of heart transplantation in recipients with type D personality.
    Denollet J; Holmes RV; Vrints CJ; Conraads VM
    J Heart Lung Transplant; 2007 Feb; 26(2):152-8. PubMed ID: 17258149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.